Image

Hannah Bedard

Associate

Hannah Bedard is an Associate at Wilkinson Stekloff. Before joining the firm, Hannah was an associate at Kirkland & Ellis in Washington, DC. She has worked on a variety of complex civil litigation matters, including patent, trade secret, contract, and False Claims Act cases. Hannah has experience in all stages of litigation and has represented clients in motions for injunctive relief, summary judgment, and post-trial relief. She has also been a member of numerous appellate teams.

Hannah maintains an active pro bono practice. She has represented clients in federal appellate courts, state courts, and agencies. Among other successes, she represented an incarcerated defendant before the Seventh Circuit and secured his release by persuading the court that his Fourth Amendment rights had been violated.

Hannah served as a law clerk to the Honorable Raymond C. Clevenger of the U.S. Court of Appeals for the Federal Circuit. She graduated from the University of Pennsylvania Law School, where she served as an executive editor of the University of Pennsylvania Law Review and a teaching assistant in intellectual property law courses.


Education

  • Undergraduate: Massachusetts Institute of Technology, B.S. (2011)
  • Law: University of Pennsylvania Law School, J.D. (2016)

Clerkship

Judge Clevenger, U.S. Court of Appeals for the Federal Circuit (2016-2017)

Notable Matters

  • Member of the team representing a major chemical manufacturer in the Aqueous Film-Forming Foams (AFFF) Products Liability Litigation in the District of South Carolina. The multi-district litigation, involving alleged PFAS groundwater contamination from the use of AFFF, is considered the most significant PFAS litigation in the country. Was set to serve as a member of the trial team for the manufacturer in the first bellwether trial in the AFFF MDL, which was halted when the remaining parties announced a settlement to end all water-provider claims brought against the manufacturer.

Publications

  • “Uncertainty in U.S. Patent Cases Following the Arthrex Decision,” Corporate Disputes, April–June 2020.
  • “What’s Next for Issue Preclusion and Patent Invalidity,” Law360, June 28, 2018.
  • “The Potential for Bioprediction in Criminal Law,” 18 Colum. Sci. & Tech. L. Rev. 268 (2017).
  • “Proposals for Fee-Shifting in American Patent Law,” Intellectual Property Law Newsletter (Pa. Bar Assoc.), Summer 2016.

Recent News